Citizens raises Raymond James stock price target on wealth management strength

Raymond James received a $200.00 price target from Citizens (from $190.00), implying ~21% upside from $165.35, while F3Q26 EPS is modeled at $3.00 (3% above consensus). The firm reported Q2 fiscal 2026 EPS of $2.83 vs. $2.76 consensus and record quarterly net revenues of $3.86B, slightly above expectations, and also declared a $0.54/share quarterly dividend (payable July 15, 2026). While BMO lifted its PT to $165 and TD Cowen cut its PT to $155 due to a weaker earnings outlook for 2026–2027, the overall takeaway is supportive fundamentals with resilience from ongoing wealth and investment banking activity.

Analysis

RJF looks more like a defensive compounder than a pure capital-markets beta trade. The market is still underpricing how much of the next few quarters can come from mix and operating leverage: fee revenue should re-rate with any stabilizing balance sheet, while loan growth can offset weak transaction volumes and push estimates up without a full M&A recovery. That makes the stock less dependent on a clean macro backdrop than higher-multiple wealth names.

Second-order, this is a relative-positive for diversified wealth platforms with embedded banking, and a relative-negative for firms whose earnings need a faster rebound in advisory/M&A activity. If RJF continues to show resilience, it can pull capital toward balance-sheet-supported wealth models like MS and UBS, while exposing more fragile fee-only platforms to multiple compression. The main loser is the "recovery in IB" trade: if pipelines are healthy but still slow to convert, the market may need to mark down 2026 optimism across the brokerage complex.

The contrarian risk is that consensus is extrapolating too quickly from one clean quarter into a sustained upcycle. Asset-based revenue is lagged, expense relief is delayed, and any stall in loan growth or a renewed drop in client cash would hit the earnings bridge before market appreciation helps. Falsifiers are simple: if F3/F4 expense leverage fails to improve, or if balance-sheet growth rolls over, the rerating case fades quickly.

Key Decisions for Investors

• Start a small long RJF on weakness, with a 3-6 month horizon; target is modest multiple expansion as NII and fee mix support EPS revisions. Risk control: cut if management does not show sequential expense leverage or if loan growth decelerates.
• Pair trade: long RJF / short LPLA for 1-2 quarters. RJF has a lower valuation and a balance-sheet cushion; LPLA is more reliant on market beta and advisor flows. Falsify if equity markets rally hard enough to reaccelerate AUM-driven growth.
• Use SCHW as the relative-value hedge rather than an outright short if rates stay elevated: RJF should hold earnings better because lending and trading diversify the revenue base. Exit the pair if cash-sweep trends improve faster than expected at SCHW.